CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-03 | MORRISSEY MICHAEL President and CEO | Gift | −16,298 | 964,384 | ||
| 2024-10-03 | MORRISSEY MICHAEL President and CEO | Gift | +16,298 | 1,453,212 | ||
| 2024-10-02 | Haley Patrick J. EVP, Commercial | Option exercise | +100,000 | $24.41 | $2.4M | 441,036 |
| 2024-10-02 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −96,111 | $26.50 | $2.5M | 344,925 |
| 2024-10-02 | Haley Patrick J. EVP, Commercial | Option exercise · Option (right to buy) | −100,000 | 0 | ||
| 2024-10-01 | MORRISSEY MICHAEL President and CEO | Option exercise | +480,000 | $24.41 | $11.7M | 1,444,384 |
| 2024-10-01 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −463,702 | $26.30 | $12.2M | 980,682 |
| 2024-10-01 | MORRISSEY MICHAEL President and CEO | Option exercise · Option (right to buy) | −480,000 | 0 | ||
| 2024-09-23 | Hessekiel Jeffrey EVP & General Counsel | Sale 10b5-1 | −25,000 | $26.38 | $660K | 605,325 |
| 2024-08-26 | Hessekiel Jeffrey EVP, General Counsel & Sec | Option exercise 10b5-1 | +20,000 | $24.41 | $488K | 650,325 |
| 2024-08-26 | Hessekiel Jeffrey EVP, General Counsel & Sec | Sale 10b5-1 | −20,000 | $25.79 | $516K | 630,325 |
| 2024-08-26 | Hessekiel Jeffrey EVP, General Counsel & Sec | Option exercise · Option (right to buy) 10b5-1 | −20,000 | 0 | ||
| 2024-08-14 | Freire Maria C Director | Sale | −8,250 | $26.56 | $219K | 91,007 |
| 2024-08-13 | Smith Julie Director | Other disposition | −4,682 | 10,778 | ||
| 2024-08-12 | Aftab Dana CSO/EVP Disc & Trans Research | Sale | −20,883 | $27.06 | $565K | 500,107 |
| 2024-08-09 | Senner Christopher J. EVP and CFO | Option exercise | +125,000 | $24.41 | $3.1M | 846,680 |
| 2024-08-09 | Senner Christopher J. EVP and CFO | Sale | −125,000 | $27.19 | $3.4M | 721,680 |
| 2024-08-09 | Senner Christopher J. EVP and CFO | Option exercise · Option (right to buy) | −125,000 | 0 | ||
| 2024-08-08 | POSTE GEORGE Director | Sale | −33,725 | $26.89 | $907K | 199,020 |
| 2024-08-07 | Aftab Dana CSO/EVP Disc & Trans Research | Option exercise 10b5-1 | +95,000 | $24.41 | $2.3M | 615,990 |
Page 13 of 20 · 381 trades